BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30307688)

  • 21. Predictive factors of overall and major postoperative complications after partial nephrectomy: Results from a multicenter prospective study (The RECORd 1 project).
    Mari A; Antonelli A; Bertolo R; Bianchi G; Borghesi M; Ficarra V; Fiori C; Furlan M; Giancane S; Longo N; Mirone V; Morgia G; Porpiglia F; Rovereto B; Schiavina R; Serni S; Simeone C; Volpe A; Carini M; Minervini A
    Eur J Surg Oncol; 2017 Apr; 43(4):823-830. PubMed ID: 27876194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intraoperative Conversion From Partial to Radical Nephrectomy: Incidence, Predictive Factors, and Outcomes.
    Petros FG; Keskin SK; Yu KJ; Li R; Metcalfe MJ; Fellman BM; Chang CM; Gu C; Tamboli P; Matin SF; Karam JA; Wood CG
    Urology; 2018 Jun; 116():114-119. PubMed ID: 29578041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [THE FACTORS THAT AFFECT THE DECISION TO PERFORM LAPAROSCOPIC PARTIAL NEPHRECTOMY FOR SMALL RENAL TUMOR].
    Kanno T; Kubota M; Sakamoto H; Nishiyama R; Oida T; Okada T; Akao T; Higashi Y; Kawamura J; Yamada H
    Nihon Hinyokika Gakkai Zasshi; 2016; 107(2):73-78. PubMed ID: 28442673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. R-LESS partial nephrectomy trifecta outcome is inferior to multiport robotic partial nephrectomy: comparative analysis.
    Komninos C; Shin TY; Tuliao P; Yoon YE; Koo KC; Chang CH; Kim SW; Ha JY; Han WK; Rha KH
    Eur Urol; 2014 Sep; 66(3):512-7. PubMed ID: 24275311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of quality indicators on adherence to National and European guidelines for renal cell carcinoma.
    Thorstenson A; Harmenberg U; Lindblad P; Ljungberg B; Lundstam S;
    Scand J Urol; 2016; 50(1):2-8. PubMed ID: 26202573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies.
    Mir MC; Derweesh I; Porpiglia F; Zargar H; Mottrie A; Autorino R
    Eur Urol; 2017 Apr; 71(4):606-617. PubMed ID: 27614693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does the Unexpected Presence of Non-organ-confined Disease at Final Pathology Undermine Cancer Control in Patients with Clinical T1N0M0 Renal Cell Carcinoma Who Underwent Partial Nephrectomy?
    Capitanio U; Stewart GD; Klatte T; Akdogan B; Roscigno M; Marszalek M; Dell'Oglio P; Zaffuto E; Rodriguez Faba O; Salagierski M; Lingard J; Carini M; Ouzaid I; Mir MC; Montorsi F; Da Pozzo LF; Stief C; Minervini A; Brookman-May SD
    Eur Urol Focus; 2018 Dec; 4(6):972-977. PubMed ID: 28753867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
    Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
    Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer-specific and non-cancer-related mortality rates in European patients with T1a and T1b renal cell carcinoma.
    Zini L; Patard JJ; Capitanio U; Crepel M; de La Taille A; Tostain J; Ficarra V; Bernhard JC; Ferrière JM; Pfister C; Villers A; Montorsi F; Karakiewicz PI
    BJU Int; 2009 Apr; 103(7):894-8. PubMed ID: 19076131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age distribution for partial and radical nephrectomy: whose nephrons are being spared?
    von Klot C; Herrmann TR; Wegener G; Kuczyk MA; Hupe MC; Akkoyun M; Peters I; Kramer MW; Merseburger AS
    Adv Ther; 2013 Oct; 30(10):924-32. PubMed ID: 24155056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumours.
    Stern JM; Svatek R; Park S; Hermann M; Lotan Y; Sagalowsky AI; Cadeddu JA
    BJU Int; 2007 Aug; 100(2):287-90. PubMed ID: 17617136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mortality, morbidity and healthcare expenditures after local tumour ablation or partial nephrectomy for T1A kidney cancer.
    Larcher A; Sun M; Dell'Oglio P; Trudeau V; Boehm K; Schiffmann J; Tian Z; Fossati N; Capitanio U; Briganti A; Montorsi F; Karakiewicz P
    Eur J Surg Oncol; 2017 Apr; 43(4):815-822. PubMed ID: 27692535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variation in Surgical Margin Status by Surgical Approach among Patients Undergoing Partial Nephrectomy for Small Renal Masses.
    Tabayoyong W; Abouassaly R; Kiechle JE; Cherullo EE; Meropol NJ; Shah ND; Dong S; Thompson RH; Smaldone MC; Zhu H; Ialacci S; Kim SP
    J Urol; 2015 Dec; 194(6):1548-53. PubMed ID: 26094808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. National Norwegian Practice Patterns for Surgical Treatment of Kidney Cancer Tumors ≤7cm: Adherence to Changes in Guidelines May Improve Overall Survival.
    Hjelle KM; Johannesen TB; Bostad L; Reisæter LAR; Beisland C
    Eur Urol Oncol; 2018 Aug; 1(3):252-261. PubMed ID: 31102628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.
    Kaushik D; Kim SP; Childs MA; Lohse CM; Costello BA; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Eur Urol; 2013 Oct; 64(4):600-6. PubMed ID: 23280319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of local tumor ablation and non-interventional management versus partial nephrectomy in T1a renal cell carcinoma.
    Palumbo C; Mistretta FA; Knipper S; Mazzone E; Pecoraro A; Tian Z; Perrotte P; Antonelli A; Montorsi F; Shariat SF; Saad F; Simeone C; Briganti A; Lavallee LT; Karakiewicz PI
    Minerva Urol Nefrol; 2020 Jun; 72(3):350-359. PubMed ID: 31487976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cryoablation versus Partial Nephrectomy for Clinical T1b Renal Tumors: A Matched Group Comparative Analysis.
    Caputo PA; Zargar H; Ramirez D; Andrade HS; Akca O; Gao T; Kaouk JH
    Eur Urol; 2017 Jan; 71(1):111-117. PubMed ID: 27568064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of survival for partial vs. radical nephrectomy in young patients with T1a renal cell carcinoma treated at commission on cancer-accredited facilities and influence of comorbidities on treatment choice.
    Wang DC; Plante K; Stewart T; Wang D; Formica M; Daugherty M; Bratslavsky G
    Urol Oncol; 2017 Nov; 35(11):660.e9-660.e15. PubMed ID: 28736248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Practice patterns for the surgical treatment of T1 renal cell carcinoma: a nationwide population-based register study.
    Ljungberg B; Gudmundsson E; Christensen S; Lundstam S;
    Scand J Urol; 2014 Oct; 48(5):445-52. PubMed ID: 24666103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
    Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
    Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.